Preferential amplification of CD8 effector-T cells after transcutaneous application of an inactivated influenza vaccine: a randomized phase I trial.

Source:http://linkedlifedata.com/resource/pubmed/id/20520820

Download in:

View as

General Info

PMID
20520820